News & Publications
Regulatory Coalition
Sign the Petition
Contact
EAASM participates in DIA Europe 2021 "Advancing Healthcare in Europe" poster session on nanomedicines
15-19 March 2021
Nanomedicines – ensuring patient safety through regulatory clarity– advocacy work by the European Alliance for Access to Safe Medicine (EAASM)
Read publication / View Video
1
2
3
4
Next »
EAASM letter highlighting the need to fully harness the potential of nanomedicines and protect patient safety across Europe
30 June 2021
Read publication
Event summary: Innovation in Nanomedicines: Enhancing Patient Safety Through Regulatory Clarity
30 November 2020
Read publication
Patient Safety & Nanomedicines
17 September 2020
The need for a centralised regulatory procedure
Read publication
Nanomedicines: Ensuring patient safety through regulatory clarity
12 July 2020
Ensuring patient safety through regulatory clarity
Read publication
News
PRESS RELEASE: Nanomedicines and Nanosimilars — The EU urgently needs a Robust Centralised Regulatory Framework to Enhance Patient Safety
24 February 2022
EVENT SUMMARY: EU Parliament Roundtable webinar on Nanomedicines – 30 November 2021
22 December 2021
PRESS RELEASE: Nanomedicines and nanosimilars: the medical need for a centralised EMA regulatory process
30 November 2021
EVENT: Nanomedicines and nanosimilars: the medical need for a centralised EMA regulatory process – 30 November 2021 – 10:00 to 11:30 CET
15 November 2021
1
2
3
Next »
Load more news articles
Publications
1
2
Next »
View all publications
The Regulatory Nanomedicines Coalition
MEP Supporters
Petar VITANOV
Bulgaria
Group of the Progressive Alliance of Socialists and Democrats in the European Parliament
Contact Us
If you would like to become a member/supporter, if you have any comments on our website, or information that you think may be of value to other readers, please contact:
Mike Isles, Executive Director
+44 7540 462867
mike.isles@eaasm.eu
Laura Cigolot, Secretariat
laura.cigolot@eaasm.eu
News
PRESS RELEASE: Nanomedicines and Nanosimilars — The EU urgently needs a Robust Centralised Regulatory Framework to Enhance Patient Safety
24 February 2022
EVENT SUMMARY: EU Parliament Roundtable webinar on Nanomedicines – 30 November 2021
22 December 2021
PRESS RELEASE: Nanomedicines and nanosimilars: the medical need for a centralised EMA regulatory process
30 November 2021
EVENT: Nanomedicines and nanosimilars: the medical need for a centralised EMA regulatory process – 30 November 2021 – 10:00 to 11:30 CET
15 November 2021
1
2
3
Next »
Latest Tweets
Tweets by EAASMeds
